Independent, head-to-head study shows significant health benefits of early fortification associated with Prolacta Bioscience’s 100% human milk-based fortifiers compared to cow milk-based fortifiers for premature infants
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Early Fortification
Should human milk-based nutritional products for premature infants be homogenized? More research is needed, new journal article says
Type: Press Releases
Topic(s): Clinical Studies on Prolact/Humavant CR Company Pasteurization Product
Prolacta Bioscience enrolls first infant in Japan-based clinical trial to evaluate the effect of an Exclusive Human Milk Diet on growth and safety in premature infants
Type: Press Releases
Topic(s): Clinical Studies
Prolacta Bioscience Appoints Dr. Anne Beal to Board of Directors
Type: Press Releases
Topic(s): Company
Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU
Type: Press Releases
Topic(s): Donors Helping Hands Tiny Treasures
Prolacta Bioscience Develops World’s First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk
Type: Press Releases
Topic(s): Company
Mindy Fuzesy presents at Association of Women's Health, Obstetric and Neonatal Nurses 2021 virtual convention
Type: Press Releases
Topic(s): Conferences and Events Pasteurization
Prolacta Bioscience continues Advancing the Science of Human Milk, proud to partner with NICU teams in saving lives of premature infants
Type: Press Releases
Topic(s): Company Healthcare Professionals
Association of Women’s Health, Obstetric, & Neonatal Nurses (AWHONN) encourages an exclusive human milk diet (EHMD) for vulnerable preterm infants in the neonatal intensive care unit (NICU)
Type: Press Releases
Topic(s): Advocacy Bronchopulmonary Dysplasia (BPD) Feeding Intolerance Late-Onset Sepsis Mortality Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)